Brief: Camurus Announces New Phase 3 Data

Camurus AB

17/07/2023 06:16

July 17 (Reuters) - Camurus AB  CAMX.ST :
    * ANNOUNCES NEW PHASE 3 DATA REINFORCING LONG-TERM SAFETY
AND
EFFICACY OF OCTREOTIDE SC DEPOT (CAM2029) IN PATIENTS WITH
ACROMEGALY
    * PHASE 3 DATA SHOW A FAVORABLE SAFETY PROFILE AND ROBUST
LONG-TERM EFFICACY OVER 52 WEEKS OF TREATMENT WITH CAM2029.

Source text for Eikon:  ID:nWkrbxj7tW 
Further company coverage:  CAMX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))